Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

IDL Biotech AB (IDLb)

Spotlight
Currency in SEK
Disclaimer
2.3800
0.0000(0.00%)
Closed
IDLb Scorecard
Fair Value
Unlock Value
Day's Range
2.28002.4000
52 wk Range
0.00002.4000
Prev. Close
2.26
Open
2.28
Day's Range
2.28-2.4
52 wk Range
0-0
Volume
0
Average Volume (3m)
7,869
1-Year Change
0%
Shares Outstanding
60,144,011
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about IDLb?
Vote to see community's results!
or

IDL Biotech Company Profile

IDL Biotech AB is a Sweden-based company that develops, manufactures and markets in vitro diagnostic (IVD) products for the healthcare sector. The Company’s products are divided into two main areas, namely Oncology and Bacteriology. Oncology includes in vitro tumor markers for various for a number of types of cancer, such as breast, lung, prostate, bladder and ovarian cancers. The markers indicate ongoing tumor cell activity, giving measurements on changes in tumor behavior, and provide early signals about the course of the disease. Oncology comprises such products as TPS, TPAcyk, UBC and MonoTotal. Bacteriology offers TUBEX TF, an in vitro diagnostic test for detection of typhoid fever (a Salmonella infection). As of December 31, 2011, the Company had one wholly owned subsidiary, namely IDL Bioscience AB.

Sector
-
Employees
12
Market
Sweden
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.